Arvinder K. Dhalla

2.5k total citations
53 papers, 2.0k citations indexed

About

Arvinder K. Dhalla is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Arvinder K. Dhalla has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Arvinder K. Dhalla's work include Cardiac electrophysiology and arrhythmias (16 papers), Adenosine and Purinergic Signaling (10 papers) and Ion channel regulation and function (7 papers). Arvinder K. Dhalla is often cited by papers focused on Cardiac electrophysiology and arrhythmias (16 papers), Adenosine and Purinergic Signaling (10 papers) and Ion channel regulation and function (7 papers). Arvinder K. Dhalla collaborates with scholars based in United States, Canada and United Kingdom. Arvinder K. Dhalla's co-authors include Pawan K. Singal, Luiz Belardinelli, Michael F. Hill, John C. Shryock, Charita Seneviratne, Gerald M. Reaven, Jeffrey W. Chisholm, Weiqun Wang, Revati Shreeniwas and Sridharan Rajamani and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Arvinder K. Dhalla

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvinder K. Dhalla United States 24 960 845 299 289 279 53 2.0k
Li‐Man Hung Taiwan 26 387 0.4× 795 0.9× 727 2.4× 129 0.4× 317 1.1× 66 2.5k
Randy L. Webb United States 29 1.8k 1.9× 1.1k 1.3× 583 1.9× 363 1.3× 178 0.6× 78 3.4k
Cherry L. Wainwright United Kingdom 24 653 0.7× 474 0.6× 363 1.2× 52 0.2× 385 1.4× 93 1.6k
Vincenzo Panagia Canada 27 1.1k 1.1× 1.4k 1.7× 414 1.4× 61 0.2× 432 1.5× 111 2.3k
Fuzhong Qin United States 28 852 0.9× 785 0.9× 420 1.4× 36 0.1× 295 1.1× 45 1.9k
Ronald E. Weishaar United States 22 968 1.0× 1.2k 1.4× 381 1.3× 62 0.2× 550 2.0× 48 2.4k
Liming Yu China 26 407 0.4× 1.1k 1.3× 517 1.7× 73 0.3× 442 1.6× 63 2.5k
Vijayan Elimban Canada 26 1.2k 1.2× 961 1.1× 298 1.0× 30 0.1× 395 1.4× 90 2.0k
Xing Chang China 26 368 0.4× 1.3k 1.6× 279 0.9× 101 0.3× 204 0.7× 56 2.2k
Per‐Ove Sjöquist Sweden 24 576 0.6× 401 0.5× 397 1.3× 37 0.1× 468 1.7× 64 1.6k

Countries citing papers authored by Arvinder K. Dhalla

Since Specialization
Citations

This map shows the geographic impact of Arvinder K. Dhalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvinder K. Dhalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvinder K. Dhalla more than expected).

Fields of papers citing papers by Arvinder K. Dhalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvinder K. Dhalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvinder K. Dhalla. The network helps show where Arvinder K. Dhalla may publish in the future.

Co-authorship network of co-authors of Arvinder K. Dhalla

This figure shows the co-authorship network connecting the top 25 collaborators of Arvinder K. Dhalla. A scholar is included among the top collaborators of Arvinder K. Dhalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvinder K. Dhalla. Arvinder K. Dhalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dam, Jacques Van, et al.. (2024). Preference for a Novel Oral Alternative to Parenterally Administered Medications. Patient Preference and Adherence. Volume 18. 1547–1562. 8 indexed citations
2.
3.
Koltun, Dmitry O., Elfatih Elzein, Tetsuya Kobayashi, et al.. (2016). Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic & Medicinal Chemistry Letters. 26(13). 3207–3211. 27 indexed citations
4.
Budas, Grant R., Faquan Liang, Dillon Phan, et al.. (2014). ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension. European Respiratory Journal. 44(Suppl 58). P2298–P2298. 3 indexed citations
5.
Fernandes, Sarah, Kirsten Hoyer, Weiqun Wang, et al.. (2014). Selective Inhibition of the Late Sodium Current has No Adverse Effect on Electrophysiological or Contractile Function of the Normal Heart. Journal of Cardiovascular Pharmacology. 63(6). 512–519. 11 indexed citations
6.
Dhalla, Arvinder K., et al.. (2013). Reduction of Free Fatty Acids, Safety, and Pharmacokinetics of Oral GS‐9667, an A1 Adenosine Receptor Partial Agonist. The Journal of Clinical Pharmacology. 53(4). 385–392. 23 indexed citations
7.
Chi, Liguo, Haiyun Ling, Dillon Phan, et al.. (2013). Abstract 15308: Reduction of LV Diastolic Wall Tension by Ranolazine Led to Improved Diastolic Coronary Blood Flow During Demand-Induced Acute Myocardial Ischemia in Anesthetized Canine. Circulation. 128. 1 indexed citations
8.
Ning, Yun, Zhen Wei, Zhuo Fu, et al.. (2011). Ranolazine Increases β-Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in Mice. Journal of Pharmacology and Experimental Therapeutics. 337(1). 50–58. 54 indexed citations
9.
Dhalla, Arvinder K., Jeffrey W. Chisholm, Gerald M. Reaven, & Luiz Belardinelli. (2009). A1 Adenosine Receptor: Role in Diabetes and Obesity. Handbook of experimental pharmacology. 271–295. 78 indexed citations
10.
Robertson, Chelsea L., et al.. (2008). Antitorsadogenic Effects of (±)-N-(2,6-Dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (Ranolazine) in Anesthetized Rabbits. Journal of Pharmacology and Experimental Therapeutics. 325(3). 875–881. 37 indexed citations
11.
Dhalla, Arvinder K., et al.. (2008). Comparison of the antilipolytic effects of an A 1 adenosine receptor partial agonist in normal and diabetic rats. Diabetes Obesity and Metabolism. 11(2). 95–101. 23 indexed citations
12.
Shearer, Jane, David L. Severson, Lin Su, Luiz Belardinelli, & Arvinder K. Dhalla. (2008). Partial A1 Adenosine Receptor Agonist Regulates Cardiac Substrate Utilization in Insulin-Resistant Rats in Vivo. Journal of Pharmacology and Experimental Therapeutics. 328(1). 306–311. 17 indexed citations
13.
Dhalla, Arvinder K., et al.. (2007). Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid. Journal of Pharmacology and Experimental Therapeutics. 321(1). 327–333. 42 indexed citations
14.
Dhalla, Arvinder K., et al.. (2006). Tachycardia Caused by A2A Adenosine Receptor Agonists Is Mediated by Direct Sympathoexcitation in Awake Rats. Journal of Pharmacology and Experimental Therapeutics. 316(2). 695–702. 85 indexed citations
15.
Dhalla, Arvinder K., et al.. (2004). 1170-142 Differential vasodilatory effects of CVT-3146, an A 2A adenosine receptor agonist in various vascular beds in anesthetized dogs. Journal of the American College of Cardiology. 43(5). A367–A368. 3 indexed citations
16.
Dhalla, Arvinder K., John C. Shryock, Revati Shreeniwas, & Luiz Belardinelli. (2003). Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands. Current Topics in Medicinal Chemistry. 3(4). 369–385. 116 indexed citations
17.
Katwa, Laxmansa C., Yao Sun, Scott E. Campbell, et al.. (1998). Pouch Tissue and Angiotensin Peptide Generation. Journal of Molecular and Cellular Cardiology. 30(7). 1401–1413. 16 indexed citations
18.
Dhalla, Arvinder K., J C Kandala, Karl T. Weber, & Ramareddy V. Guntaka. (1997). Identification of negative and positive regulatory elements in the rat α1(I) collagen gene promoter. The International Journal of Biochemistry & Cell Biology. 29(1). 143–151. 8 indexed citations
19.
Dhalla, Arvinder K., Michael F. Hill, & Pawan K. Singal. (1996). Role of oxidative stress in transition of hypertrophy to heart failure. Journal of the American College of Cardiology. 28(2). 506–514. 344 indexed citations
20.
Dhalla, Arvinder K., Neelam Khaper, & Pawan K. Singal. (1996). Complete Stunning in Hypertrophied Guinea Pig Heart. Annals of the New York Academy of Sciences. 793(1). 142–155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Man Hung Breakdown of academic impact, for papers by Randy L. Webb Breakdown of academic impact, for papers by Cherry L. Wainwright Breakdown of academic impact, for papers by Vincenzo Panagia Breakdown of academic impact, for papers by Fuzhong Qin Breakdown of academic impact, for papers by Ronald E. Weishaar Breakdown of academic impact, for papers by Liming Yu Breakdown of academic impact, for papers by Vijayan Elimban Breakdown of academic impact, for papers by Xing Chang Breakdown of academic impact, for papers by Per‐Ove Sjöquist
Rankless by CCL
2026